ENGLEWOOD, Colo., March 21,
2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an
innovative medical technology company specializing in the
manufacture and sale of non-invasive medical devices for pain
management, rehabilitation, and patient monitoring, today announced
the Denver Business Journal has ranked Zynex sixth in a list
of the largest Denver-area
Biotechnology/Bioscience companies, according to the number of
full-time employees (FTEs).
"Zynex has experienced significant revenue and order growth over
the last several years, and we have invested heavily in the
expansion of our quality workforce" said Thomas Sandgaard, CEO and founder of Zynex Inc.
"We remain committed to being a high-quality workplace and industry
leader in the Denver-area."
About Denver Business Journal
American City
Business Journals (ACBJ) is the largest publisher of metropolitan
business newsweeklies in the United
States, with 44 business publications across the country
reaching more than 3.6 million readers each week.
About Zynex, Inc.
Zynex, founded in 1996,
develops, manufactures, markets, and sells medical devices used for
pain management and rehabilitation as well as non-invasive fluid,
sepsis, and laser-based pulse oximetry monitoring systems for use
in hospitals. For additional information, please
visit: www.zynex.com
Contact: Zynex, Inc. (800) 495-6670
Investor Relations Contact:
Gilmartin Group
Investor Relations Counsel
ir@zynex.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zynex-included-in-denver-areas-top-10-biotechnologybioscience-companies-301777101.html
SOURCE Zynex